Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet

A. J. Armstrong, E. S. Antonarakis, M. E. Taplin, W. K. Kelly, H. Beltran, K. Fizazi, W. L. Dahut, N. Shore, S. Slovin, D. George, M. A. Carducci, P. Corn, D. Danila, R. Dreicer, E. Heath, D. Rathkopf, G. Liu, D. Nanus, M. Stein, M. R. SmithC. Sternberg, G. Wilding, P. S. Nelson, S. Halabi, P. Kantoff, N. W. Clarke, Christopher P Evans, A. Heidenreich, N. Mottet, M. Gleave, M. J. Morris, H. I. Scher

Research output: Contribution to journalEditorial

4 Scopus citations
Original languageEnglish (US)
Article numbermdx648
Pages (from-to)23-25
Number of pages3
JournalAnnals of Oncology
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Armstrong, A. J., Antonarakis, E. S., Taplin, M. E., Kelly, W. K., Beltran, H., Fizazi, K., Dahut, W. L., Shore, N., Slovin, S., George, D., Carducci, M. A., Corn, P., Danila, D., Dreicer, R., Heath, E., Rathkopf, D., Liu, G., Nanus, D., Stein, M., ... Scher, H. I. (2018). Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet. Annals of Oncology, 29(1), 23-25. [mdx648]. https://doi.org/10.1093/annonc/mdx648